Together these results are consistent with an enhanced sensitivity to PARPi in RB1-mutant osteosarcomas and identify rapid cell death as a key consequence of PARPi exposure in osteosarcoma cells with this genetic defect. This evidence concerns the gene RB1 and osteosarcoma.